DMTS

DRUG3 trials

Sponsors

Teikoku Pharma USA, Inc., Sichuan Academy of Medical Sciences

Conditions

Multiple Sclerosis (MS) Relapsing RemittingPain, Postoperative

Phase 2

Dexmedetomidine Transdermal System (DMTS) for Post-Operative Analgesia Following Bunionectomy

CompletedNCT02953054

Teikoku Pharma USA, Inc.Pain, Postoperative

Start: 2017-01-22End: 2017-07-03Updated: 2017-10-09

Evaluating Efficacy of the Dexmedetomidine Transdermal System for Postoperative Analgesia Following Abdominoplasty

Teikoku Pharma USA, Inc.Pain, Postoperative

Start: 2020-07-07End: 2021-02-01Target: 164Updated: 2020-07-23

A Multicenter Clinical Trial Evaluating the Efficacy and Safety of Taurine as an Adjunctive Therapy in Multiple Sclerosis

Not yet recruitingNCT07263607

Sichuan Academy of Medical SciencesMultiple Sclerosis (MS) Relapsing Remitting

Start: 2026-01-01End: 2029-11-30Target: 80Updated: 2025-12-04